Total submissions: 22
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000041614 | SCV000050839 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000041614 | SCV000065310 | likely benign | not specified | 2012-11-05 | criteria provided, single submitter | clinical testing | Pro1090Leu in exon 18 of SCN5A: This variant is not expected to have clinical si gnificance because it has been identified in 2.1% (12/572) of chromosomes from a broad, though clinically and racially unspecified population from 1000 Genomes Project (http://1000genomes.org; rs1805125). Pro1090Leu in exon 18 of SCN5A (r s1805125; allele frequency = 2.1%, 12/572) |
Gene |
RCV000041614 | SCV000171566 | benign | not specified | 2011-11-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000058559 | SCV000291798 | benign | not provided | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000242258 | SCV000318823 | benign | Cardiovascular phenotype | 2015-03-25 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001841602 | SCV000902961 | benign | Cardiac arrhythmia | 2018-03-19 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852963 | SCV000995712 | likely benign | Hypertrophic cardiomyopathy | 2018-05-08 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001149367 | SCV001310316 | likely benign | Ventricular fibrillation, paroxysmal familial, type 1 | 2018-05-09 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001149368 | SCV001310317 | likely benign | Long QT syndrome 3 | 2018-05-09 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001149369 | SCV001310318 | likely benign | Brugada syndrome 1 | 2018-05-09 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001149370 | SCV001310319 | likely benign | Dilated cardiomyopathy 1E | 2018-05-09 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001149371 | SCV001310320 | benign | Sick sinus syndrome 1 | 2018-05-09 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001149372 | SCV001310321 | likely benign | Progressive familial heart block, type 1A | 2018-05-09 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Molecular Genetics Laboratory, |
RCV001084763 | SCV001338813 | benign | Brugada syndrome | 2019-05-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002483030 | SCV002797349 | likely benign | Brugada syndrome 1; Long QT syndrome 3; Sick sinus syndrome 1; Progressive familial heart block, type 1A; Ventricular fibrillation, paroxysmal familial, type 1; Dilated cardiomyopathy 1E; SUDDEN INFANT DEATH SYNDROME; Atrial fibrillation, familial, 10 | 2022-05-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000058559 | SCV004033983 | benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | SCN5A: PP3, BS1, BS2 |
ARUP Laboratories, |
RCV000058559 | SCV004563062 | likely benign | not provided | 2023-11-09 | criteria provided, single submitter | clinical testing | |
Cardiovascular Biomedical Research Unit, |
RCV000058559 | SCV000090079 | not provided | not provided | no assertion provided | literature only | This variant has been reported in the following publications (PMID:10807545;PMID:15689442;PMID:16155735;PMID:18426444;PMID:19841300;PMID:20129283). | |
Clinical Genetics, |
RCV000041614 | SCV001920603 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000041614 | SCV001928174 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000041614 | SCV001953296 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000058559 | SCV001974458 | likely benign | not provided | no assertion criteria provided | clinical testing |